HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

K Gotanda Selected Research

TZA 2237

10/2000Effects of a new steroidal aromatase inhibitor, TZA-2237, and/or chlormadinone acetate on hormone-induced and spontaneous canine benign prostatic hyperplasia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


K Gotanda Research Topics

Disease

1Atrophy
01/2003
1Prostatic Neoplasms (Prostate Cancer)
01/2003
1Prostatic Hyperplasia (Benign Prostatic Hyperplasia)
10/2000

Drug/Important Bio-Agent (IBA)

1Leuprolide (Lupron)FDA LinkGeneric
01/2003
1Gonadotropin-Releasing Hormone (GnRH)FDA Link
01/2003
1Aromatase InhibitorsIBA
10/2000
1Chlormadinone Acetate (Chlormadinone)IBA
10/2000
1Hormones (Hormone)IBA
10/2000
1TZA 2237IBA
10/2000

Therapy/Procedure

1Therapeutics
01/2003